<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03614507</url>
  </required_header>
  <id_info>
    <org_study_id>FreeO2Bronchio (29BRC18.0091)</org_study_id>
    <nct_id>NCT03614507</nct_id>
  </id_info>
  <brief_title>Automation of Oxygen Delivery in Spontaneous Ventilation (FreeO2) in Infants</brief_title>
  <acronym>FreeO2Bronchio</acronym>
  <official_title>Automation of Oxygen Delivery in Spontaneous Ventilation (FreeO2) in Infants Under One Year Old With Bronchiolitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Brest</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Brest</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to demonstrate a decrease in the duration of hospitalization
      in case of first oxygen-dependent bronchiolitis thanks to the use of the FreeO2 system in
      infants less than 1 year old. The advantage of using FreeO2 system would be to shorten the
      duration of hospitalization.

      FreeO2Bronchio is a multicenter, prospective, randomized, open-label study.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a multi-center, randomized, open-controlled, multicentre trial. Patients will be
      included after a compendium of informed and express consent from both parents. They will then
      be randomized either in the &quot;FreeO2&quot; arm or in the &quot;manual&quot; arm for Oxygen therapy with
      manual flow adjustment. The SpO2 will be recorded continuously in both arms of the study
      using the FREEO2 device throughout the duration of hospitalization; In the arm &quot;FreeO2 &quot; The
      device will record the data continuously and allow the automation of oxygen administration -
      in the arm &quot;Manual&quot;, the device is only used in the monitoring mode of SpO2 and heart rate.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 9, 2018</start_date>
  <completion_date type="Anticipated">November 2020</completion_date>
  <primary_completion_date type="Anticipated">October 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>This is a multicenter, prospective, randomized, open-label study. Patients will then be randomized to either the &quot;FreeO2 Arm&quot; or the &quot;Manual Arm&quot; for Oxygen Therapy with Manual Flow Adaptation.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
    <masking_description>The technology used does not allow blinding.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Duration of hospitalization in hours since the entrance to the emergency room.</measure>
    <time_frame>30 days max</time_frame>
    <description>The length of hospital stay in hours since arrival at the emergency room will be compared between the two groups.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Re-hospitalization within 7 days and 30 days</measure>
    <time_frame>30 days max</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Frequency of use of ventilation (invasive or noninvasive )</measure>
    <time_frame>30 days max</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Transfer to continuous care units or resuscitation within 3 days</measure>
    <time_frame>30 days max</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time spent in enteral nutrition on gastric tube in hours</measure>
    <time_frame>30 days max</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time spent under intravenous hydration in hours</measure>
    <time_frame>30 days max</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reports of AEs</measure>
    <time_frame>30 days max</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time spent in a area of severe desaturation (SpO2 &lt;92%) and a hyperoxia area (SpO2&gt; 98%).</measure>
    <time_frame>30 days max</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Frequency of use of high-speed glasses (Optiflow)</measure>
    <time_frame>30 days max</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">170</enrollment>
  <condition>Bronchiolitis</condition>
  <arm_group>
    <arm_group_label>FreeO2 Arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Automatic adjustment of oxygen</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Manual Arm</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Manual adjustment of oxygen</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>FreeO2 (modèle FO2-220-00) automatic adjustment</intervention_name>
    <description>Automatic adjustment of oxygen through the &quot;Free O2&quot; device and in mode medical data collecting (SpO2)</description>
    <arm_group_label>FreeO2 Arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>FreeO2 (modèle FO2-220-00) manual adjustment</intervention_name>
    <description>Manual adjustment of oxygen by the nurse or medical staff. The &quot;Free O2&quot; device will only be used in mode medical data collecting (SpO2)</description>
    <arm_group_label>Manual Arm</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Children older than 1 month and less than 1 year of age who have a first episode of
             bronchiolitis and require oxygen therapy

          -  Informed consent of parents

          -  Affiliation to the social security system

        Exclusion Criteria:

          -  Need for an oxygen flow rate higher than 3 L / min to maintain SpO2 greater than 92%

          -  Patient with a severe form according to 2019 HAS criteria and needing to maintain SpO2
             greater than 94%

          -  Criteria of gravity justifying from the start another technique of respiratory
             assistance:

               -  Polypnea: respiratory rate (FR)&gt; 80 c / min.

               -  Consciousness with glasgow score (GSC) &lt;or = 12. Hemodynamic instability (mean
                  arterial pressure (MAP) &lt;- 2 SD for age or use of vasopressors).

               -  Cardiac or respiratory arrest.

               -  PCO2&gt; 55 mm Hg and pH &lt;7.20 if blood gas sample

          -  Need for urgent surgery

          -  Contraindication to the FreeO2 device as described in the user manual

          -  Absence of informed consent of parents

          -  Birth term less than 36 SA

          -  Severe Co-morbidity (cystic fibrosis, immune deficiency, complex heart disease,
             neuromuscular illness)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Month</minimum_age>
    <maximum_age>1 Year</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Michel ROUE, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU de Brest</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jean-Michel ROUE, Dr</last_name>
    <phone>02 98 22 36 67</phone>
    <phone_ext>+33</phone_ext>
    <email>jean-michel.roue@chu-brest.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Angers, University Hospital</name>
      <address>
        <city>Angers</city>
        <zip>49993</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Françoise TROUSSIER, Dr</last_name>
      <email>frtroussier@chu-angers.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Brest, University Hospital</name>
      <address>
        <city>Brest</city>
        <zip>29609</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Michel ROUE, Dr</last_name>
      <email>jean-michel.roue@chu-brest.fr</email>
    </contact>
    <contact_backup>
      <last_name>Pierrick CROS, Dr</last_name>
      <email>pierrick.cros@chu-brest.fr</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>La-Roche-Sur-Yon, Departmental Hospital Center</name>
      <address>
        <city>La Roche-sur-Yon</city>
        <zip>85000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xavier MICAELLI, Dr</last_name>
      <email>xavier.micaelli@chd-vendee.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Limoges, University Hospital</name>
      <address>
        <city>Limoges</city>
        <zip>87000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rachel FROGET, Dr</last_name>
      <email>Rachel.FROGET@chu-limoges.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Marseille, University Hospital</name>
      <address>
        <city>Marseille</city>
        <zip>13285</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ania CARSIN, Dr</last_name>
      <email>ania.carsin@ap-hm.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>La Timone, University Hospital</name>
      <address>
        <city>Marseille</city>
        <zip>13385</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Christophe DUBUS, Dr</last_name>
      <email>jeanchristophe.dubus@ap-hm.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Nantes, University Hospital</name>
      <address>
        <city>Nantes</city>
        <zip>44093</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tiphaine BIHOUEE, Dr</last_name>
      <email>tiphaine.bihouee@chu-nantes.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Lenval, University Hospital</name>
      <address>
        <city>Nice</city>
        <zip>06200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisa GIOVANNINI-CHAMI, Dr</last_name>
      <email>giovannini-chami.l@pediatrie-chulenval-nice.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Rennes, university Hospital</name>
      <address>
        <city>Rennes</city>
        <zip>35000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Clémentine VIGIER, Dr</last_name>
      <email>clementine.vigier@chu-rennes.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>July 30, 2018</study_first_submitted>
  <study_first_submitted_qc>July 30, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 3, 2018</study_first_posted>
  <last_update_submitted>April 6, 2020</last_update_submitted>
  <last_update_submitted_qc>April 6, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 7, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>oxygen dependent</keyword>
  <keyword>Infant Between 1 Month and 12 Months Old</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bronchiolitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

